| |
| |
|
| Insider
Information: |
Cullen Michael T. |
| Relationship: |
Director, 10% Owner |
| City: |
Waconia |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
216,811 |
|
|
Indirect Shares
|
369,576 |
|
|
| Direct
Value |
$1,489,492 |
|
|
|
Indirect Value
|
$2,538,987 |
|
|
| Total
Shares |
586,387 |
|
|
| Total
Value |
$4,028,479 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Panbela Therapeutics, Inc. |
PBLA |
Director, 10% Owner |
2022-10-04 |
216,811 |
2022-10-04 |
369,576 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PBLA |
Panbela Therapeutics, Inc... |
Director |
• • • |
2022-10-04 |
4 |
B |
$0.00 |
$0 |
I/I |
165,000 |
369,576 |
2.17 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Director |
• • • |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,316 |
216,811 |
0 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Exec. Chairman, Pres. & CEO |
• • • |
2020-09-01 |
4 |
B |
$0.00 |
$0 |
D/D |
10,000 |
207,995 |
3.15 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Exec. Chairman, Pres. & CEO |
• • • |
2020-05-22 |
4/A |
B |
$0.00 |
$0 |
I/I |
10,000 |
204,576 |
2.56 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Exec. Chairman, Pres. & CEO |
• • • |
2020-05-22 |
4 |
B |
$0.00 |
$0 |
D/D |
10,000 |
207,995 |
3.15 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Exec. Chairman, Pres. & CEO |
• • • |
2019-08-30 |
4 |
B |
$0.00 |
$0 |
D/D |
30,000 |
197,995 |
3.15 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Exec. Chairman, Pres. & CEO |
• • • |
2019-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,495 |
167,995 |
0 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Executive Chairman |
• • • |
2018-02-20 |
4 |
B |
$0.00 |
$0 |
I/I |
5,000 |
194,576 |
2.56 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Executive Chairman |
• • • |
2016-12-21 |
5 |
GD |
$0.00 |
$0 |
D/D |
45,000 |
1,575,000 |
0 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Executive Chairman |
• • – |
2016-06-24 |
4 |
B |
$0.00 |
$0 |
I/I |
50,000 |
1,895,764 |
2.58 |
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Director |
– • – |
2015-09-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,845,764 |
|
- |
|
| PBLA |
Panbela Therapeutics, Inc... |
Director |
– • – |
2015-09-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,620,000 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
